News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
The mass spec technology company plans to bring three products to market in the next year, including an integrated LC-MEA device and an ion source.
The system is designed to detect single amino acid polymorphisms in touch skin samples that can be used to identify specific people.
The researchers used the method, which is based on the Pup bacterial protein, to identify interaction partners of the T cell membrane receptor CD28.
The company said the funds will be used to expand its management team and complete commercialization of its mass spec multinozzle emitter array technology.
The company, which has just changed its name from Sygnis, has now completed the integration of several recent acquisitions including TGR Biosciences.
Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.
In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.
At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.
The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.
This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.